BioSpace News Archive

Chimerix today announced that it will host a live conference call and audio webcast on Thursday, November 4, 2021 at 8:30 a.m. ET to report financial results for the third quarter ended September 30, 2021, and to provide an operational update.

NuVasive, Inc. today announced it will sponsor and participate in the Society for Minimally Invasive Spine Surgery (SMISS) Annual Forum ’21 in Las Vegas from October 28 to 30, 2021.

PaxMedica, Inc. today announced that it has presented additional data and analyses from its Phase 2 clinical trial evaluating PAX-101

There’s a new drug in development that could prevent the next global pandemic. Researchers at Texas A&M University Health Science Center ( Texas A&M Health ) and University of Texas MD Anderson Cancer Center are testing PUL-042, an inhaled therapeutic that provides broad protection against a range of life-threatening respiratory infections.

OpGen, Inc. announced today that the Company will provide a business update and report its third quarter 2021 financial results after the close of the U.S. financial markets on Thursday, November 11, 2021.

Kura Oncology, Inc. today announced that it will report third quarter 2021 financial results after the close of U.S. financial markets on Thursday, November 4, 2021.

Labcorp today announced results for the third quarter ended September 30, 2021, and raised full-year guidance.

Diffusion Pharmaceuticals Inc. will participate in the 2021 Alliance Global Partners Biotech & Specialty Pharma Conference taking place November 10, 2021.

Provention Bio, Inc. today announced that it will report its third quarter 2021 financial results on Thursday, November 4, 2021 , before the opening of the U.S. financial markets.

Organon (NYSE: OGN), will release its third quarter 2021 financial results on November 11, 2021, prior to the company’s webcast and conference call scheduled for 8:30 a.m. ET.